Deprenyl
Apoptosis Inhibitor
Product Specifications
Background
Deprenyl or Selegiline is a drug used for the treatment of early stage Parkinson's (1), depression and senile dementia (2). It is a selective irreversable inhibitor of monoamine oxidase B (MAO-b).
CAS Number
14611-52-0
Product Name Alternative
N-Methyl-N-[ (2R) -1-phenyl-2-propanyl]-2-propyn-1-amine, Selegiline
UNSPSC
41116105
Type
Inhibitor
Source
Synthetic
Field of Research
Cancer | Apoptosis | Neuroscience | Neurodegeneration | Parkinson's Disease
Purity
>98% (TLC) ; NMR (Conforms)
Weight
1
Format
White Solid
Solubility
May be dissolved in water (25mg/mL)
Molecular Formula
C13H17N·HCl
Molecular Weight
223.74
Precautions
Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
References & Citations
1. Lachenmayer L., and Laux G. (2004) Curr Med Chem. 11(15): 2033-2043.
2. FDA US Food and Drug Administration. Press Announcements Feb 28, 2006. www.fda.gov/newsevents/newsroom/pressannouncements/2006/ucm108607.htm
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
